Schroth Physiotherapeutic Scoliosis-Specific Exercise (PSSE) Trials-Systematic Review of Methods and Recommendations for Future Research.
Sanja SchreiberDaniel WhibleyEmily C SomersPublished in: Children (Basel, Switzerland) (2023)
The Schroth method is a non-operative treatment for scoliosis and kyphosis, used standalone or as an adjunct to bracing. While supporting evidence for its effectiveness is emerging, methodologic standardization and rigor are equivocal. Thus, we aimed to systematically review methods of published Schroth physiotherapeutic scoliosis-specific exercise (PSSE) trials and provide guidance for future research. We searched six databases for randomized controlled trials (RCT) and non-randomized studies of interventions (NRSIs) investigating the effect of Schroth in children and adults with scoliosis or kyphosis. General characteristics, methodological approaches, treatment protocols, and outcomes reporting were analyzed. Risk of bias (RoB) was assessed using an adapted Cochrane RoB2 tool for RCTs and ROBINS-I for NRSI. Eligible studies ( n = 7) were conducted in six countries and included patients with Scheuermann's kyphosis ( n = 1) and adolescent idiopathic scoliosis ( n = 6). Though all seven studies used the term Schroth to describe their interventions, the Schroth method was used in four of seven studies, of which only one used Schroth classification, three used Schroth therapists, and none prospectively registered the study protocol. Overall, methodological rigor was suboptimal, potentially invalidating evidence synthesis. Authors should follow minimum standards for reporting, including prospectively registering detailed protocols; using appropriate exercise labeling, Schroth classification and certified therapists; naming and describing exercises per classification; and providing therapy dosages, prescription methods, and adherence.
Keyphrases
- systematic review
- randomized controlled trial
- physical activity
- machine learning
- high intensity
- deep learning
- study protocol
- case control
- meta analyses
- open label
- double blind
- clinical trial
- emergency department
- young adults
- preterm infants
- weight loss
- adverse drug
- combination therapy
- phase ii
- cell therapy
- insulin resistance
- electronic health record